Clinical Manual for Management of the HIV-Infected ... - myCME.com

3–36 | Clinical Manual for Management of the HIV-Infected Adult/2006
♦
♦
♦
♦
♦
♦
♦
♦
♦
Centers for Disease Control and Prevention.
Advancing HIV prevention: new strategies for a
changing epidemic—United States, 2003. MMWR.
2003 Apr 18;52(15):329-32. Available online
at www.cdc.gov/mmwr/preview/mmwrhtml/
mm5215a1.htm.
Centers for Disease Control and Prevention. Public
Health Service Task Force Recommendations for Use
of Antiretroviral Drugs in Pregnant HIV-1-Infected
Women for Maternal Health and Interventions to
Reduce Perinatal HIV-1 Transmission in the United
States. October 12, 2006. Available online at
aidsinfo.nih.gov/Guidelines/GuidelineDetail.
aspx?GuidelineID=9. Accessed July 8, 2007.
Centers for Disease Control and Prevention. Revised
recommendations for HIV screening of pregnant women.
MMWR Recomm Rep. 2001 Nov 9;50(RR-19):63-
85. Available online at www.cdc.gov/mmwr/preview/
mmwrhtml/rr5019a2.htm. Accessed May 19, 2006.
Centers for Disease Control and Prevention.
Recommendations of the U.S. Public Health Service
Task Force on the use of zidovudine to reduce perinatal
transmission of human immunodeficiency virus.
MMWR Recomm Rep. 1994 Aug 5;43(RR-11):1-
20.
Chou R, Smits AK, Huffman LH, et al. Prenatal
screening for HIV: A review of the evidence for the U.S.
Preventive Services Task Force. Ann Intern Med. 2005
Jul 5;143(1):38-54.
Connor EM, Sperling RS, Gelber R, et al.
Reduction of maternal-infant transmission of human
immunodeficiency virus type 1 with zidovudine
treatment. Pediatric AIDS Clinical Trials Group
Protocol 076 Study Group. N Engl J Med. 1994
Nov 3;331(18):1173-80.
Cooper ER, Charurat M, Mofenson L, et al.
Combination antiretroviral strategies for the treatment
of pregnant HIV-1-infected women and prevention of
perinatal HIV-1 transmission. J Acquir Immune Defic
Syndr. 2002 Apr 15;29(5):484-94.
European Collaborative Study, Swiss Mother and
Child HIV Cohort Study. Combination antiretroviral
therapy and duration of pregnancy. AIDS. 2000 Dec
22;14(18):2913-20.
Fowler MG, Simonds RJ, Roongpisuthipong A.
Update on perinatal HIV transmission. Pediatr Clin
North Am. 2000 Feb;47(1):21-38.
♦
♦
♦
♦
♦
♦
♦
♦
♦
Garcia PM, Kalish LA, Pitt J. et al. Maternal levels of
plasma human immunodeficiency virus type 1 RNA and
the risk of perinatal transmission. Women and Infants
Transmission Study Group. N Engl J Med. 1999
Aug 5;341(6):394-402.
Gray RH, Li X, Kigozi G, et al. Increased risk
of incident HIV during pregnancy in Rakai,
Uganda: a prospective study. Lancet. 2005 Oct
1;366(9492):1182-8.
Guay LA, Musoke P, Fleming T, et al. Intrapartum
and neonatal single-dose nevirapine compared
with zidovudine for prevention of mother-tochild
transmission of HIV-1 in Kampala, Uganda:
HIVNET 012 randomised trial. Lancet. 1999 Sep
4;354(9181):795-802.
Institute of Medicine, Committee on Perinatal
Transmission of HIV, Commission on Behavioral
and Social Sciences and Education, et al. Stoto M,
Almario D, McCormick M, eds. Reducing the Odds:
Preventing Perinatal Transmission of HIV in the
United States. Washington, DC: National Academy
Press; 1999.
International Perinatal HIV Group. Duration of
ruptured membranes and vertical transmission of HIV-
1: a meta-analysis from 15 prospective cohort studies.
AIDS. 2001 Feb 16;15(3):357-68.
Ioannidis JP, Abrams EJ, Ammann A, et al. (2001).
Perinatal transmission of human immunodeficiency
virus type 1 by pregnant women with RNA virus
loads